Sign up UNITED KINGDOM
Proactive Investors - Run By Investors For Investors
Why invest in BCT?
Bluechiip: THE INVESTMENT CASE

Bluechiip: Access latest PPT from Proactive's CEO Sessions

Andrew McLellan discussed with investors wiresless tracking technology.
Bluechiip: Access latest PPT from Proactive's CEO Sessions
INVESTMENT OVERVIEW: BCT The Big Picture
Andrew McLellan, MD, bluechiip

Bluechiip's (ASX:BCT) managing director, Andrew McLellan, joined Proactive's CEO Sessions in Sydney on Tuesday 14th March and Melbourne on Wednesday 15th March.

Bluechiip has developed an IT based temperature and identification tracking solution for biosamples in the health and life sciences industry.

The company has a growing partner pipeline and growing revenues.

 

ACCESS THE FULL PRESENTATION HERE

 



Register here to be notified of future BCT Company articles
View full BCT profile View Profile

Bluechiip Timeline

Newswire
August 11 2016
Newswire
December 15 2015
Newswire
September 16 2015
Newswire
August 28 2014

Related Articles

Call service droids
March 08 2017
Between now and 2018, Panmure Gordon sees a compound annualised growth rate for profit in excess of 100%
pioneering_tech_-__smart_burner_-_woman_hands_fire.png
May 17 2017
In 2016, Pioneering's market capitalization increased by 1,170% and its share price appreciated by 725%.
shutterstock_302650592_58dc0a99d5fca.jpg
March 29 2017
This week the firm has bolstered its coffers to the tune of over $20mln via a now closed bought deal financing.

© Proactive Investors 2017

Proactive Investor UK Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use